ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 434 filers reported holding ENCOMPASS HEALTH CORP in Q1 2024. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $823 | +91.4% | 9,661 | +72.4% | 0.00% | 0.0% |
Q1 2024 | $430 | +15.6% | 5,605 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $372 | -0.5% | 5,605 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $374 | -100.0% | 5,605 | -76.6% | 0.00% | -66.7% |
Q3 2022 | $1,081,000 | -97.0% | 24,000 | -96.3% | 0.00% | -97.2% |
Q2 2022 | $36,402,000 | -19.6% | 650,979 | +2.2% | 0.11% | -3.6% |
Q1 2022 | $45,299,000 | +7.2% | 636,941 | -0.9% | 0.11% | +6.8% |
Q4 2021 | $42,276,000 | -9.8% | 642,541 | +4.8% | 0.10% | -21.4% |
Q3 2021 | $46,886,000 | +5555.7% | 612,991 | +5687.8% | 0.13% | +6450.0% |
Q2 2021 | $829,000 | +163.2% | 10,591 | +178.7% | 0.00% | +100.0% |
Q1 2021 | $315,000 | +303.8% | 3,800 | +300.0% | 0.00% | – |
Q4 2020 | $78,000 | -60.8% | 950 | -71.2% | 0.00% | -100.0% |
Q2 2020 | $199,000 | -13.9% | 3,304 | -10.7% | 0.00% | -50.0% |
Q1 2020 | $231,000 | -64.7% | 3,700 | -60.7% | 0.00% | -50.0% |
Q4 2019 | $654,000 | – | 9,417 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
RK Capital | 115,800 | $7,525,000 | 2.13% |
Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |